These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22268178)

  • 1. Epithelial malignant pleural mesothelioma after extrapleural pneumonectomy: stratification of survival with CT-derived tumor volume.
    Gill RR; Richards WG; Yeap BY; Matsuoka S; Wolf AS; Gerbaudo VH; Bueno R; Sugarbaker DJ; Hatabu H
    AJR Am J Roentgenol; 2012 Feb; 198(2):359-63. PubMed ID: 22268178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and pathological features of three-year survivors of malignant pleural mesothelioma following extrapleural pneumonectomy.
    Sugarbaker DJ; Wolf AS; Chirieac LR; Godleski JJ; Tilleman TR; Jaklitsch MT; Bueno R; Richards WG
    Eur J Cardiothorac Surg; 2011 Aug; 40(2):298-303. PubMed ID: 21310625
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extrapleural pneumonectomy versus pleurectomy/decortication in the surgical management of malignant pleural mesothelioma: results in 663 patients.
    Flores RM; Pass HI; Seshan VE; Dycoco J; Zakowski M; Carbone M; Bains MS; Rusch VW
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):620-6, 626.e1-3. PubMed ID: 18329481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant pleural mesothelioma: surgical management in 285 patients.
    Schipper PH; Nichols FC; Thomse KM; Deschamps C; Cassivi SD; Allen MS; Pairolero PC
    Ann Thorac Surg; 2008 Jan; 85(1):257-64; discussion 264. PubMed ID: 18154820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
    Sugarbaker DJ; Flores RM; Jaklitsch MT; Richards WG; Strauss GM; Corson JM; DeCamp MM; Swanson SJ; Bueno R; Lukanich JM; Baldini EH; Mentzer SJ
    J Thorac Cardiovasc Surg; 1999 Jan; 117(1):54-63; discussion 63-5. PubMed ID: 9869758
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of extrapleural pneumonectomy in malignant pleural mesothelioma. A Lung Cancer Study Group trial.
    Rusch VW; Piantadosi S; Holmes EC
    J Thorac Cardiovasc Surg; 1991 Jul; 102(1):1-9. PubMed ID: 2072706
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The value of occult disease in resection margin and lymph node after extrapleural pneumonectomy for malignant mesothelioma.
    Mineo TC; Ambrogi V; Pompeo E; Baldi A; Stella F; Aurea P; Marino M
    Ann Thorac Surg; 2008 May; 85(5):1740-6. PubMed ID: 18442576
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The importance of surgical staging in the treatment of malignant pleural mesothelioma.
    Rusch VW; Venkatraman E
    J Thorac Cardiovasc Surg; 1996 Apr; 111(4):815-25; discussion 825-6. PubMed ID: 8614142
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extrapleural pneumonectomy for malignant pleural mesothelioma: outcomes of treatment and prognostic factors.
    Yan TD; Boyer M; Tin MM; Wong D; Kennedy C; McLean J; Bannon PG; McCaughan BC
    J Thorac Cardiovasc Surg; 2009 Sep; 138(3):619-24. PubMed ID: 19698846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors in the treatment of malignant pleural mesothelioma at a large tertiary referral center.
    Flores RM; Zakowski M; Venkatraman E; Krug L; Rosenzweig K; Dycoco J; Lee C; Yeoh C; Bains M; Rusch V
    J Thorac Oncol; 2007 Oct; 2(10):957-65. PubMed ID: 17909360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Staging of patients after extrapleural pneumonectomy for malignant pleural mesothelioma--institutional review and current update.
    Cao C; Krog Andvik SK; Yan TD; Kennedy C; Bannon PG; McCaughan BC
    Interact Cardiovasc Thorac Surg; 2011 May; 12(5):754-7. PubMed ID: 21303872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Updated patterns of failure after multimodality therapy for malignant pleural mesothelioma.
    Baldini EH; Richards WG; Gill RR; Goodman BM; Winfrey OK; Eisen HM; Mak RH; Chen AB; Kozono DE; Bueno R; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2015 May; 149(5):1374-81. PubMed ID: 25772281
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Outcome after extrapleural pneumonectomy for malignant pleural mesothelioma.
    Aigner C; Hoda MA; Lang G; Taghavi S; Marta G; Klepetko W
    Eur J Cardiothorac Surg; 2008 Jul; 34(1):204-7. PubMed ID: 18407510
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical indications and results after chest wall resection for recurrent mesothelioma.
    Burt BM; Ali SO; DaSilva MC; Yeap BY; Richards WG; Baldini EH; Sugarbaker DJ
    J Thorac Cardiovasc Surg; 2013 Dec; 146(6):1373-9; discussion 1379-80. PubMed ID: 24113019
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pleurectomy/decortication is superior to extrapleural pneumonectomy in the multimodality management of patients with malignant pleural mesothelioma.
    Lang-Lazdunski L; Bille A; Lal R; Cane P; McLean E; Landau D; Steele J; Spicer J
    J Thorac Oncol; 2012 Apr; 7(4):737-43. PubMed ID: 22425923
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Morbidity, mortality, mean survival, and the impact of histology on survival after pleurectomy in 64 patients with malignant pleural mesothelioma.
    Neragi-Miandoab S; Richards WG; Sugarbaker DJ
    Int J Surg; 2008 Aug; 6(4):293-7. PubMed ID: 18585112
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multimodal therapy for malignant pleural mesothelioma including extrapleural pneumonectomy].
    Sienel W; Kirschbaum A; Passlick B
    Zentralbl Chir; 2008 Jun; 133(3):231-7. PubMed ID: 18563687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adoption of pleurectomy and decortication for malignant mesothelioma leads to similar survival as extrapleural pneumonectomy.
    Batirel HF; Metintas M; Caglar HB; Ak G; Yumuk PF; Yildizeli B; Yuksel M
    J Thorac Cardiovasc Surg; 2016 Feb; 151(2):478-84. PubMed ID: 26611742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low calretinin expression and high neutrophil-to-lymphocyte ratio are poor prognostic factors in patients with malignant mesothelioma undergoing extrapleural pneumonectomy.
    Kao SC; Klebe S; Henderson DW; Reid G; Chatfield M; Armstrong NJ; Yan TD; Vardy J; Clarke S; van Zandwijk N; McCaughan B
    J Thorac Oncol; 2011 Nov; 6(11):1923-9. PubMed ID: 22011651
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical techniques for multimodality treatment of malignant pleural mesothelioma: extrapleural pneumonectomy and pleurectomy/decortication.
    Wolf AS; Daniel J; Sugarbaker DJ
    Semin Thorac Cardiovasc Surg; 2009; 21(2):132-48. PubMed ID: 19822285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.